Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants

Total Page:16

File Type:pdf, Size:1020Kb

Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants Journal of Clinical Medicine Article Antibacterial Activity of Some Flavonoids and Organic Acids Widely Distributed in Plants Artur Adamczak 1 , Marcin O˙zarowski 2 and Tomasz M. Karpi ´nski 3,* 1 Department of Botany, Breeding and Agricultural Technology of Medicinal Plants, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland; [email protected] 2 Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630 Pozna´n,Poland; [email protected] 3 Department of Medical Microbiology, Pozna´nUniversity of Medical Sciences, Wieniawskiego 3, 61-712 Pozna´n,Poland * Correspondence: [email protected] Received: 21 November 2019; Accepted: 27 December 2019; Published: 31 December 2019 Abstract: Among natural substances widespread in fruits, vegetables, spices, and medicinal plants, flavonoids and organic acids belong to the promising groups of bioactive compounds with strong antioxidant and anti-inflammatory properties. The aim of the present work was to evaluate the antibacterial activity of 13 common flavonoids (flavones, flavonols, flavanones) and 6 organic acids (aliphatic and aromatic acids). The minimal inhibitory concentrations (MICs) of selected plant substances were determined by the micro-dilution method using clinical strains of four species of pathogenic bacteria. All tested compounds showed antimicrobial properties, but their biological activity was moderate or relatively low. Bacterial growth was most strongly inhibited by salicylic acid (MIC = 250–500 µg/mL). These compounds were generally more active against Gram-negative bacteria: Escherichia coli and Pseudomonas aeruginosa than Gram-positive ones: Enterococcus faecalis and Staphylococcus aureus. An analysis of the antibacterial effect of flavone, chrysin, apigenin, and luteolin showed that the presence of hydroxyl groups in the phenyl rings A and B usually did not influence on the level of their activity. A significant increase in the activity of the hydroxy derivatives of flavone was observed only for S. aureus. Similarly, the presence and position of the sugar group in the flavone glycosides generally had no effect on the MIC values. Keywords: kaempferol; naringin; orientin; rutin; vitexin; chlorogenic acid; citric acid; malic acid; quinic acid; rosmarinic acid 1. Introduction Screening biological studies of chemical compounds of natural origin allow for assessment of their activity and determine further research stages in order to search for new therapeutic solutions based on active compounds known in plants. This is especially important during the observed increasing resistance of bacteria and fungi to antibiotics. Multidrug resistance (MDR) is a serious threat to human health, but also to crops and animals. MDR is a growing challenge in medicine. Recently, several multinational studies have been carried out to determine the prevalence of herbal medicine use in infections due to pathogenic microorganisms [1,2]. It is considered that extracts of medicinal plants can be an alternative source of resistance modifying substances [2]. It is well known that plant extracts and other herbal products are complex mixtures containing the wide variety of primary and secondary metabolites, and their action may be the result of the synergy of different chemical components. Moreover, these extracts may show various mechanisms of biological and pharmacological activity, i.e., ability to bind to protein domains, modulation of the immune response, J. Clin. Med. 2020, 9, 109; doi:10.3390/jcm9010109 www.mdpi.com/journal/jcm J. Clin. Med. 2019, 8, x FOR PEER REVIEW 2 of 16 J. Clin. Med. 2020, 9, 109 2 of 17 interact with the environment and other organisms, therefore their chemical composition and the mitosis,level apoptosis, of active substances and signal transductioncan be very diverse [2]. However, [3,4]. In itaddition, should be th notede manufacturing that plants process interact of with herbal the environmentmedicinal products and other is very organisms, complex therefore because their it encompasses chemical composition non-standardized and the levelprocesses of active like the substancescultivation can beof veryplants, diverse obtaining [3,4]. the In addition,vegetable the ra manufacturingw material from process various of herbalparts medicinalof the world, productspreparing is very of complex extract, becauseand producing it encompasses a product non-standardized in accordance processeswith local like guidelines the cultivation of the ofgood plants,manufacturing obtaining the practice. vegetable Therefore, raw material it can from be co variousncluded parts that of using the world, pure preparingchemical compounds of extract, of andnatural producing origin a product would be in an accordance interesting with complementar local guidelinesy option of thedue goodto their manufacturing easier therapeutic practice. dosage, Therefore,the study it can of mechanisms be concluded of that the usingpharmacological pure chemical action compounds and monitoring of natural of their origin side would effects. be an interestingA complementarylot of widespread option plant due substances, to their easier including therapeutic alkaloids, dosage, organosulfur the study compounds, of mechanisms phenolic of the pharmacologicalacids, flavonoids, action carotenoids, and monitoring coumarins, of their terpenes, side etannins,ffects. and some primary metabolites (amino acids,A lot ofpeptides, widespread organic plant acids) substances, exhibit antimicrob includingial alkaloids, properties organosulfur [1,5–8]. Am compounds,ong them, flavonoids phenolic are acids,a promising flavonoids, group carotenoids, of bioactive coumarins, substances terpenes, with tannins,low systemic and some toxicity. primary Natural metabolites flavonols, (amino flavones, acids,flavanones, peptides, organicand other acids) compounds exhibit antimicrobial of this class be propertieslong to the [1 ,5common–8]. Among secondary them, flavonoidsmetabolites are found a promisingin various group fruits, of bioactive vegetables, substances and withmedicinal low systemic plants toxicity.[9] showing Natural strong flavonols, antioxidant flavones, and flavanones,anti-inflammatory and other compounds properties of[10,11]. this class Dietary belong polyphenols to the common such secondaryas flavonoids metabolites and phenolic found inacids, variousconsumed fruits, vegetables, in large quantities and medicinal in foods plants of plant [9] showing origin, exhibit strong a antioxidant number of andbeneficial anti-inflammatory effects and play propertiesan important [10,11]. role Dietary in the polyphenols prevention of such chronic as flavonoids and degenerative and phenolic diseases. acids, Not consumed only their inantioxidant large quantitiesand anti-inflammatory in foods of plant origin, activities, exhibit but a number also ofne beneficialuroprotective, effects anticancer, and play an importantimmunomodulatory, role in the preventionantidiabetic, of chronicand anti-adipogenic and degenerative properties diseases. have Not onlybeen their shown antioxidant [12,13]. andBiological anti-inflammatory availability of activities,dietary but polyphenols also neuroprotective, is low as anticancer,compared immunomodulatory,with micro- and macronutrients. antidiabetic, andTheir anti-adipogenic absorption in the propertiessmall haveintestine been shownamounts [12 ,13only]. Biological about 5–10%. availability However, of dietary recent polyphenols studies is lowshowed as compared that these withphytochemicals micro- and macronutrients. exhibit prebiotic Their properties absorption and antimicrobial in the small activity intestine against amounts pathogenic only aboutintestinal 5–10%.microflora However, [13]. recent studies showed that these phytochemicals exhibit prebiotic properties and antimicrobialFlavonoids activity selected against for pathogenicour microbiological intestinal microfloratests are [presented13]. in Figure 1. In the large quantities,Flavonoids they selected occur in for stems our and microbiological leaves, flowers tests as well are presentedas fruits of the in Figurespecies1 .from In thethe largefamilies of quantities,Apiaceae, they Asteraceae, occur in stemsBetulaceae, and leaves,Brassicaceae, flowers Ericaceae, as well asFabaceae, fruits of Hypericaceae, the species from Lamiaceae, the familiesLiliaceae, of Apiaceae, Passifloraceae, Asteraceae, Polygonaceae, Betulaceae, Primulaceae, Brassicaceae, Ericaceae,Ranunculaceae, Fabaceae, Rosaceae, Hypericaceae, Rubiaceae, Lamiaceae,Rutaceae, Liliaceae, Scrophulariaceae, Passifloraceae, Tiliaceae, Polygonaceae, and Violaceae. Primulaceae, Two Ranunculaceae, flavonols: quercetin, Rosaceae, kaempferol, Rubiaceae, and Rutaceae,flavones: Scrophulariaceae, apigenin, luteolin Tiliaceae, belong to and the Violaceae. most ubiquitous Two flavonols: plant flavonoids quercetin, [14]. kaempferol, A glycoside andform of flavones:quercetin—rutin apigenin, luteolin (sophori belongn, rutoside) to the most is ubiquitouspresent in plant the flavonoidshighest concentrations [14]. A glycoside in formbuckwheat of quercetin—rutin(Fagopyrum esculentum (sophorin, Moench), rutoside) isrue present (Ruta ingraveolens the highest L.), concentrationsflower buds of in Styphnolobium buckwheat (Fagopyrum japonicum (L.) esculentumSchott Moench),(Sophora japonica rue (Ruta L.), graveolens apricots,L.), peaches, flower budsand citrus of Styphnolobium fruits [15,16]. japonicum Apigenin(L.) derivatives, Schott (Sophora such as vitexin, isovitexin,
Recommended publications
  • Antioxidant and Inhibition of Elastase Effect of Scutellarein and Apigenin
    American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) ISSN (Print) 2313-4410, ISSN (Online) 2313-4402 © Global Society of Scientific Research and Researchers http://asrjetsjournal.org/ Antioxidant and Inhibition of Elastase Effect of Scutellarein and Apigenin Leo Tjermina*, I Nyoman Ehrich Listerb, Ali Napiah Nasutionc, Ermi Girsangd a,b,cFaculty of Medicine, University of Prima Indonesia, Medan, North Sumatera, Indonesia dFaculty of Public Health, University of Prima Indonesia, Medan, North Sumatera, Indonesia aEmail: [email protected] Abstract Aging process in the skin was begun from the time when one is born, especially skin. Cutaneous aging can be caused by intrinsic and/or extrinsic factors. Wrinkles, thinning, and roughening of skin are part of skin aging. It becomes important looking for natural sources to prevent aging process. Apigenin and Scutellarein are potential phytochemistry which have antioxidant and anti-elastase effects. The purpose of this study is investigate antioxidant and anti-elastase effects of Apigenin and Flavonoid. Determination of Antioxidant Activity of Apigenin and Scutellarien was using FRAP Methods while anti-elastase activity was determined by inhibition of Elastase from Porcine Pancreas. The result of this study was expressed by Mean ± SD and analyzed by One Way analysis of variance (ANOVA) and Turkey HSD Post Hoc Test as a Further Analysis. Both of Scutellarein or Apigenin had the most potent antioxidant activity at the highest concentration (50 µg/ml). The FRAP Activity of Scutellarein or Apigenin at Highest concentration are 250.22 ±2.3 and 29.05 ±5.88 µg Fe (II), respectively. Antioxidant activity of Scutellarein are more potent than apigenin at various concentration and was shown differences at P value < 0.05.
    [Show full text]
  • A Cytotoxic C-Glycosylated Derivative of Apigenin from the Leaves Of
    Revista Brasileira de Farmacognosia 26 (2016) 763–766 ww w.elsevier.com/locate/bjp Short communication A cytotoxic C-glycosylated derivative of apigenin from the leaves of Ocimum basilicum var. thyrsiflorum a,b,∗ c,d Mohamed I.S. Abdelhady , Amira Abdel Motaal a Pharmacognosy Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt b Pharmacognosy Department, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia c Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt d Pharmaceutical Biology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), Cairo, Egypt a b s t r a c t a r t i c l e i n f o Article history: The standardized 80% ethanolic extract of the leaves of Ocimum basilicum var. thyrsiflorum (L.) Benth., Received 12 February 2016 Lamiaceae, growing in KSA, exhibited a significant antioxidant activity compared to the ethyl acetate and Accepted 7 June 2016 butanol extracts, which was correlated to its higher phenolic and flavonoid contents. Chromatographic Available online 20 July 2016 separation of the 80% ethanol extract resulted in the isolation of ten known compounds; cinnamic acid, gallic acid, methylgallate, ellagic acid, methyl ellagic acid, apigenin, luteolin, vitexin, isovitexin, and 3 -O- Keywords: acetylvitexin. Compound 3 -O-acetylvitexin, a C-glycosylated derivative of apigenin, was isolated for the Ocimum basilicum first time from genus Ocimum. The 80% ethanolic extract and 3 -O-acetylvitexin showed significant cyto- HCT116 toxic activities against the HCT human colon cancer cell line [IC values 22.3 ± 1.1 and 16.8 ± 2.0 ␮g/ml Cytotoxic 116 50 ␮ Antioxidant (35.4 M), respectively].
    [Show full text]
  • Characterization of C-Glycosidic Flavonoids from Brazilian Passiflora Species Using Lc/Ms Exact Mass Measurement
    CHARACTERIZATION OF C-GLYCOSIDIC FLAVONOIDS FROM BRAZILIAN PASSIFLORA SPECIES USING LC/MS EXACT MASS MEASUREMENT 1 2 2 NOTE M. McCullagh , C.A.M. Pereira , J.H. Yariwake 1Waters Corporation, Floats Road, Wythenshawe, Manchester, M23 9LZ, UK 2Universidade de São Paulo, Instituto de Química de São Carlos, São Carlos, SP, Brazil OVERVIEW This application note describes the analysis of extracts Recently issues have arisen with Kava Kava, a natural from Passiflora species using real time centroid exact health product, which is used for its anti-depressant and mass measurement. The system used comprised of an anti-anxiety properties. Investigations into the safety of LCT™ orthogonal acceleration (oa-TOF) time of flight Kava have taken place within several European mass spectrometer with LockSpray™ source, Waters® countries, including Germany, U.K., Switzerland, 2996 PDA and Waters Alliance® HT 2795 France, Spain and parts of Scandinavia. In Switzerland Separations Module. and Germany cases of liver damage were reported. In Application the US the FDA has investigated Kava's safety, where INTRODUCTION as in Canada the public were advised not to take the EU Directive 2001/83/EC will regulate and produce a supplement until product safety could be assured. The set of harmonized assessment criteria for the efficacy Kava market in Germany alone is $25m. Proving the and safety "Herbal Medicinal Products for traditional efficacy of such a product is economically viable. use". The current and future E.U. member states will Such issues illustrate how regulation currently affects produce and abide by this directive, making 28 states the natural health product market and also why new in total.
    [Show full text]
  • Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem
    Supplementary materials Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim, Injae Song, Yen T. K. Nguyen, Suckchang Hong, Byung Woo Han, Ho-Young Lee - 1 - Table S1. Short tandem repeat (STR) DNA profiles for human cancer cell lines used in this study. MDA-MB-231 Marker H1299 H460 A549 HCT116 (MDA231) Amelogenin XX XY XY XX XX D8S1179 10, 13 12 13, 14 10, 14, 15 13 D21S11 32.2 30 29 29, 30 30, 33.2 D7S820 10 9, 12 8, 11 11, 12 8 CSF1PO 12 11, 12 10, 12 7, 10 12, 13 D3S1358 17 15, 18 16 12, 16, 17 16 TH01 6, 9.3 9.3 8, 9.3 8, 9 7, 9.3 D13S317 12 13 11 10, 12 13 D16S539 12, 13 9 11, 12 11, 13 12 D2S1338 23, 24 17, 25 24 16 21 D19S433 14 14 13 11, 12 11, 14 vWA 16, 18 17 14 17, 22 15 TPOX 8 8 8, 11 8, 9 8, 9 D18S51 16 13, 15 14, 17 15, 17 11, 16 D5S818 11 9, 10 11 10, 11 12 FGA 20 21, 23 23 18, 23 22, 23 - 2 - Table S2. Antibodies used in this study. Catalogue Target Vendor Clone Dilution ratio Application1) Number 1:1000 (WB) ADI-SPA- 1:50 (IHC) HSP70 Enzo C92F3A-5 WB, IHC, IF, IP 810-F 1:50 (IF) 1 :1000 (IP) ADI-SPA- HSP90 Enzo 9D2 1:1000 WB 840-F 1:1000 (WB) Oct4 Abcam ab19857 WB, IF 1:100 (IF) Nanog Cell Signaling 4903S D73G4 1:1000 WB Sox2 Abcam ab97959 1:1000 WB ADI-SRA- Hop Enzo DS14F5 1:1000 WB 1500-F HIF-1α BD 610958 54/HIF-1α 1:1000 WB pAkt (S473) Cell Signaling 4060S D9E 1:1000 WB Akt Cell Signaling 9272S 1:1000 WB pMEK Cell Signaling 9121S 1:1000 WB (S217/221) MEK Cell Signaling 9122S 1:1000
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • In Vitro Metabolism of Six C-Glycosidic Flavonoids from Passiflora Incarnata L
    International Journal of Molecular Sciences Article In Vitro Metabolism of Six C-Glycosidic Flavonoids from Passiflora incarnata L. Martina Tremmel 1, Josef Kiermaier 2 and Jörg Heilmann 1,* 1 Department of Pharmaceutical Biology, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany; [email protected] 2 Department of Central Analytics, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany; [email protected] * Correspondence: [email protected] Abstract: Several medical plants, such as Passiflora incarnata L., contain C-glycosylated flavonoids, which may contribute to their efficacy. Information regarding the bioavailability and metabolism of these compounds is essential, but not sufficiently available. Therefore, the metabolism of the C-glycosylated flavones orientin, isoorientin, schaftoside, isoschaftoside, vitexin, and isovitexin was investigated using the Caco-2 cell line as an in vitro intestinal and epithelial metabolism model. Isovitexin, orientin, and isoorientin showed broad ranges of phase I and II metabolites containing hy- droxylated, methoxylated, and sulfated compounds, whereas schaftoside, isoschaftoside, and vitexin underwent poor metabolism. All metabolites were identified via UHPLC-MS or UHPLC-MS/MS using compound libraries containing all conceivable metabolites. Some structures were confirmed via UHPLC-MS experiments with reference compounds after a cleavage reaction using glucuronidase and sulfatase. Of particular interest is the observed cleavage of the C–C bonds between sugar and aglycone residues in isovitexin, orientin, and isoorientin, resulting in unexpected glucuronidated or sulfated luteolin and apigenin derivatives. These findings indicate that C-glycosidic flavones can be Citation: Tremmel, M.; Kiermaier, J.; highly metabolized in the intestine.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,101,662 B2 Tamarkin Et Al
    USOO91 01662B2 (12) United States Patent (10) Patent No.: US 9,101,662 B2 Tamarkin et al. (45) Date of Patent: *Aug. 11, 2015 (54) COMPOSITIONS WITH MODULATING A61K 47/32 (2013.01); A61 K9/0014 (2013.01); AGENTS A61 K9/0031 (2013.01); A61 K9/0034 (2013.01); A61 K9/0043 (2013.01); A61 K (71) Applicant: Foamix Pharmaceuticals Ltd., Rehovot 9/0046 (2013.01); A61 K9/0048 (2013.01); (IL) A61 K9/0056 (2013.01) (72) Inventors: Dov Tamarkin, Macabim (IL); Meir (58) Field of Classification Search Eini, Ness Ziona (IL); Doron Friedman, CPC ........................................................ A61 K9/12 Karmei Yosef (IL); Tal Berman, Rishon See application file for complete search history. le Ziyyon (IL); David Schuz, Gimzu (IL) (56) References Cited (73) Assignee: Foamix Pharmaceuticals Ltd., Rehovot U.S. PATENT DOCUMENTS (IL) 1,159,250 A 11/1915 Moulton (*) Notice: Subject to any disclaimer, the term of this 1,666,684 A 4, 1928 Carstens patent is extended or adjusted under 35 1924,972 A 8, 1933 Beckert 2,085,733. A T. 1937 Bird U.S.C. 154(b) by 0 days. 2,390,921 A 12, 1945 Clark This patent is Subject to a terminal dis 2,524,590 A 10, 1950 Boe claimer. 2,586.287 A 2/1952 Apperson 2,617,754 A 1 1/1952 Neely 2,767,712 A 10, 1956 Waterman (21) Appl. No.: 14/045,528 2.968,628 A 1/1961 Reed 3,004,894 A 10/1961 Johnson et al. (22) Filed: Oct. 3, 2013 3,062,715 A 11/1962 Reese et al.
    [Show full text]
  • Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times
    Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times Each volume in this series provides academia, health sciences, and the herbal medicines industry with in-depth coverage of the herbal remedies for infectious diseases, certain medical conditions, or the plant medicines of a particular country. Series Editor: Dr. Roland Hardman Volume 1 Shengmai San, edited by Kam-Ming Ko Volume 2 Rasayana: Ayurvedic Herbs for Rejuvenation and Longevity, by H.S. Puri Volume 3 Sho-Saiko-To: (Xiao-Chai-Hu-Tang) Scientific Evaluation and Clinical Applications, by Yukio Ogihara and Masaki Aburada Volume 4 Traditional Medicinal Plants and Malaria, edited by Merlin Willcox, Gerard Bodeker, and Philippe Rasoanaivo Volume 5 Juzen-taiho-to (Shi-Quan-Da-Bu-Tang): Scientific Evaluation and Clinical Applications, edited by Haruki Yamada and Ikuo Saiki Volume 6 Traditional Medicines for Modern Times: Antidiabetic Plants, edited by Amala Soumyanath Volume 7 Bupleurum Species: Scientific Evaluation and Clinical Applications, edited by Sheng-Li Pan Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Bruno Burlando, Luisella Verotta, Laura Cornara, and Elisa Bottini-Massa Cover art design by Carlo Del Vecchio. CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-1-4398-1214-3 (Ebook-PDF) This book contains information obtained from authentic and highly regarded sources.
    [Show full text]
  • WO 2012/159639 Al 29 November 2012 (29.11.2012)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/159639 Al 29 November 2012 (29.11.2012) (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, A23L 1/30 (2006.01) A61K 36/48 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, A61K 36/185 (2006.01) A61K 36/8962 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, A61K 36/63 (2006.01) A61K 36/54 (2006.01) HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, A61K 36/23 (2006.01) A61K 36/71 (2006.01) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, A61K 36/9066 (2006.01) A61K 36/886 (2006.01) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, A61K 36/28 (2006.01) A61K 36/53 (2006.01) OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, A61K 36/82 (2006.01) A61K 36/64 (2006.01) SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, A61K 36/67 (2006.01) TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/EG20 12/0000 18 kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (22) International Filing Date: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 22 May 2012 (22.05.2012) TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (26) Publication Language: English TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: ML, MR, NE, SN, TD, TG).
    [Show full text]
  • Pharmaceutical and Veterinary Compounds and Metabolites
    PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES High quality reference materials for analytical testing of pharmaceutical and veterinary compounds and metabolites. lgcstandards.com/drehrenstorfer [email protected] LGC Quality | ISO 17034 | ISO/IEC 17025 | ISO 9001 PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES What you need to know Pharmaceutical and veterinary medicines are essential for To facilitate the fair trade of food, and to ensure a consistent human and animal welfare, but their use can leave residues and evidence-based approach to consumer protection across in both the food chain and the environment. In a 2019 survey the globe, the Codex Alimentarius Commission (“Codex”) was of EU member states, the European Food Safety Authority established in 1963. Codex is a joint agency of the FAO (Food (EFSA) found that the number one food safety concern was and Agriculture Office of the United Nations) and the WHO the misuse of antibiotics, hormones and steroids in farm (World Health Organisation). It is responsible for producing animals. This is, in part, related to the issue of growing antibiotic and maintaining the Codex Alimentarius: a compendium of resistance in humans as a result of their potential overuse in standards, guidelines and codes of practice relating to food animals. This level of concern and increasing awareness of safety. The legal framework for the authorisation, distribution the risks associated with veterinary residues entering the food and control of Veterinary Medicinal Products (VMPs) varies chain has led to many regulatory bodies increasing surveillance from country to country, but certain common principles activities for pharmaceutical and veterinary residues in food and apply which are described in the Codex guidelines.
    [Show full text]
  • Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns
    molecules Review Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns Johra Khan 1,†, Prashanta Kumar Deb 2,3,†, Somi Priya 4 , Karla Damián Medina 5, Rajlakshmi Devi 2, Sanjay G. Walode 6 and Mithun Rudrapal 6,*,† 1 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia; [email protected] 2 Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, Assam, India; [email protected] (P.K.D.); [email protected] (R.D.) 3 Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India 4 University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India; [email protected] 5 Food Technology Unit, Centre for Research and Assistance in Technology and Design of Jalisco State A.C., Camino Arenero 1227, El Bajío del Arenal, Zapopan 45019, Jalisco, Mexico; [email protected] 6 Rasiklal M. Dhariwal Institute of Pharmaceutical Education & Research, Chinchwad, Pune 411019, Maharashtra, India; [email protected] * Correspondence: [email protected]; Tel.: +91-8638724949 † These authors contributed equally to this work. Citation: Khan, J.; Deb, P.K.; Priya, S.; Medina, K.D.; Devi, R.; Walode, S.G.; Abstract: Flavonoids comprise a large group of structurally diverse polyphenolic compounds of Rudrapal, M. Dietary Flavonoids: plant origin and are abundantly found in human diet such as fruits, vegetables, grains, tea, dairy Cardioprotective Potential with products, red wine, etc. Major classes of flavonoids include flavonols, flavones, flavanones, flavanols, Antioxidant Effects and Their anthocyanidins, isoflavones, and chalcones. Owing to their potential health benefits and medicinal Pharmacokinetic, Toxicological and significance, flavonoids are now considered as an indispensable component in a variety of medicinal, Therapeutic Concerns.
    [Show full text]
  • Distribution of Flavonoids Among Malvaceae Family Members – a Review
    Distribution of flavonoids among Malvaceae family members – A review Vellingiri Vadivel, Sridharan Sriram, Pemaiah Brindha Centre for Advanced Research in Indian System of Medicine (CARISM), SASTRA University, Thanjavur, Tamil Nadu, India Abstract Since ancient times, Malvaceae family plant members are distributed worldwide and have been used as a folk remedy for the treatment of skin diseases, as an antifertility agent, antiseptic, and carminative. Some compounds isolated from Malvaceae members such as flavonoids, phenolic acids, and polysaccharides are considered responsible for these activities. Although the flavonoid profiles of several Malvaceae family members are REVIEW REVIEW ARTICLE investigated, the information is scattered. To understand the chemical variability and chemotaxonomic relationship among Malvaceae family members summation of their phytochemical nature is essential. Hence, this review aims to summarize the distribution of flavonoids in species of genera namely Abelmoschus, Abroma, Abutilon, Bombax, Duboscia, Gossypium, Hibiscus, Helicteres, Herissantia, Kitaibelia, Lavatera, Malva, Pavonia, Sida, Theobroma, and Thespesia, Urena, In general, flavonols are represented by glycosides of quercetin, kaempferol, myricetin, herbacetin, gossypetin, and hibiscetin. However, flavonols and flavones with additional OH groups at the C-8 A ring and/or the C-5′ B ring positions are characteristic of this family, demonstrating chemotaxonomic significance. Key words: Flavones, flavonoids, flavonols, glycosides, Malvaceae, phytochemicals INTRODUCTION connate at least at their bases, but often forming a tube around the pistils. The pistils are composed of two to many connate he Malvaceae is a family of flowering carpels. The ovary is superior, with axial placentation, with plants estimated to contain 243 genera capitate or lobed stigma. The flowers have nectaries made with more than 4225 species.
    [Show full text]